Solar Biotech Inc. Completes Acquisition of Noblegen Inc.
Solar Biotech Inc. (“Solar”), a Norton, Virginia-based provider of complete sustainable and scalable biomanufacturing solutions, completed the acquisition of Noblegen Inc. (“Noblegen”), an advanced digital biology company based in Peterborough, Ontario. Going forward, Noblegen will operate under the name Solar Biotech Canada, continuing as Solar’s food-grade-certified (SQF9) biomanufacturing and research & development hub in Canada. The new company will leverage both partners’ strengths in microbiology and biomanufacturing to offer revolutionary biotech and synthetic biology solutions for a wide range of applications.
Wildeboer Dellelce acted for Noblegen with a team comprised of Rebecca Cochrane and Katie Drury (M&A and Corporate/Securities), and Marija Tasevska (Tax).
Latest News